Does HAP CareSource (Michigan) cover Zepbound or Wegovy?
Last updated
Michigan cut obesity-only GLP-1 coverage in January 2026; morbid obesity is now required.
If it is not covered: the lowest cash prices now

Without insurance: compounded tirzepatide on a monthly plan, not FDA-approved
$69/mo + $199/yr membership · about $86 a month over a year with the membership · first order: membership free for the first 21 days, never charged if you cancel before

Without insurance: compounded semaglutide on a monthly plan, not FDA-approved
$59/mo + $199/yr membership · about $76 a month over a year with the membership · first order: membership free for the first 21 days, never charged if you cancel before
Michigan cut obesity-only GLP-1 coverage in January 2026; morbid obesity is now required. HAP CareSource passes on Michigan Medicaid's reduction of coverage for GLP-1s prescribed only to treat obesity. In its words: "Coverage of GLP-1 medications when prescribed solely to treat obesity, including requests for continuation, will be reduced." (HAP CareSource, Update of Pharmacy Drug Coverage for Treatment of Obesity (provider notice), caresource.com, Jan 1, 2026, read Nov 19, 2026). A request for obesity now needs the patient to be classified as morbidly obese, among other criteria. In its words: "Patient must be classified as morbidly obese; and" (HAP CareSource, Update of Pharmacy Drug Coverage for Treatment of Obesity (provider notice), caresource.com, read Nov 19, 2026).
HAP CareSource (Michigan), Zepbound and Wegovy: common questions
Does HAP CareSource (Michigan) cover Zepbound for weight loss?
Michigan cut obesity-only GLP-1 coverage in January 2026; morbid obesity is now required. HAP CareSource passes on Michigan Medicaid's reduction of coverage for GLP-1s prescribed only to treat obesity. In its words: "Coverage of GLP-1 medications when prescribed solely to treat obesity, including requests for continuation, will be reduced." (HAP CareSource, Update of Pharmacy Drug Coverage for Treatment of Obesity (provider notice), caresource.com, Jan 1, 2026, read Nov 19, 2026). A request for obesity now needs the patient to be classified as morbidly obese, among other criteria. In its words: "Patient must be classified as morbidly obese; and" (HAP CareSource, Update of Pharmacy Drug Coverage for Treatment of Obesity (provider notice), caresource.com, read Nov 19, 2026). Zepbound not covered: the cash price at your dose
Does HAP CareSource (Michigan) cover Wegovy for weight loss?
Michigan cut obesity-only GLP-1 coverage in January 2026; morbid obesity is now required. HAP CareSource passes on Michigan Medicaid's reduction of coverage for GLP-1s prescribed only to treat obesity. In its words: "Coverage of GLP-1 medications when prescribed solely to treat obesity, including requests for continuation, will be reduced." (HAP CareSource, Update of Pharmacy Drug Coverage for Treatment of Obesity (provider notice), caresource.com, Jan 1, 2026, read Nov 19, 2026). A request for obesity now needs the patient to be classified as morbidly obese, among other criteria. In its words: "Patient must be classified as morbidly obese; and" (HAP CareSource, Update of Pharmacy Drug Coverage for Treatment of Obesity (provider notice), caresource.com, read Nov 19, 2026). Wegovy not covered: the cash price at your dose
Does Michigan Medicaid cover Wegovy or Zepbound for weight loss?
Yes, but narrowly: Michigan Medicaid is one of the 13 programs KFF counted covering GLP-1s for obesity treatment as of January 2026 (KFF, Medicaid Coverage of and Spending on GLP-1s (January 2026), kff.org/medicaid/medicaid-coverage-of-and-spending-on-glp-1s, read Nov 17, 2026), and its own criteria, effective Jan 1, 2026, say: "GLP-1 product coverage requested for treatment of obesity will require additional clinical PA requirements such as the following: Patient must be classified as morbidly obese; and Coverage is contingent on documented failure of all other clinically appropriate weight-loss interventions" (Michigan MDHHS letter L 25-73, michigan.gov, read Nov 17, 2026). Utah, Massachusetts, and Rhode Island have ended theirs since, by their own notices, and Michigan is not among them. Every program must still cover some uses: in KFF's words, "coverage of GLP-1 drugs for the treatment of obesity remains optional for states, while coverage is required for drugs approved for the treatment of diabetes and, since March 2024 and December 2024, for the treatment of cardiovascular disease (Wegovy) and moderate to severe obstructive sleep apnea in adults with obesity (Zepbound), respectively". Michigan Medicaid and GLP-1s: the state's words, and the cash price
Is HAP CareSource (Michigan) dropping GLP-1 coverage for weight loss?
Michigan cut obesity-only GLP-1 coverage in January 2026; morbid obesity is now required. HAP CareSource passes on Michigan Medicaid's reduction of coverage for GLP-1s prescribed only to treat obesity. In its words: "Coverage of GLP-1 medications when prescribed solely to treat obesity, including requests for continuation, will be reduced." (HAP CareSource, Update of Pharmacy Drug Coverage for Treatment of Obesity (provider notice), caresource.com, Jan 1, 2026, read Nov 19, 2026).
What do Zepbound and Wegovy cost if HAP CareSource (Michigan) does not cover them?
Zepbound costs $299/28 days at 2.5 mg and $449/28 days at 15 mg without insurance at Amazon Pharmacy and LillyDirect (Eli Lilly), checked Nov 19, 2026 on pharmacy.amazon.com and zepbound.lilly.com. At 15 mg, the terms: at Amazon Pharmacy, through Dec 31, 2026, with Lilly's self-pay card, whose terms on Lilly's Zepbound savings page say "Card expires and savings end on 12/31/2026" and require each refill within 45 days of the previous delivery, or Lilly's regular $699 applies; at LillyDirect (Eli Lilly), Self Pay Journey price with a refill within 45 days; otherwise $499 at 7.5 mg or $699 at 10 to 15 mg. Wegovy costs $199/28 days, through Dec 31, 2026 at 0.25 mg and $349/28 days at 2.4 mg without insurance at Amazon Pharmacy and NovoCare (Novo Nordisk), checked on pharmacy.amazon.com Nov 19, 2026 and on novocare.com Nov 11, 2026. Compounded, not FDA-approved: compounded tirzepatide from $69/mo + $199/yr membership at Collective (about $86 a month over a year with the membership) among sellers that serve Michigan; compounded semaglutide from $59/mo + $199/yr membership at Collective (about $76 a month over a year with the membership) among sellers that serve Michigan. Every GLP-1's cash price without insurance
GLPcompare links out only to sellers with a referral program: if you sign up or buy through one of those links, we may earn a commission at no extra cost to you. For other sellers we show the price and the seller's address, and suggest sellers we can link to. It never changes the price you pay or the underlying data. Our default order is lowest price first, with sellers that pay us moved up, and the note under each list says which order it shows; every lowest-cost sort uses the price alone. In a price table, a partner's offer says so in its terms. The order is not a medical recommendation; a higher-placed offer is not necessarily the lowest price or the right product for you.